GlassScriptPhysician profile
Obinna U Nwobi
NPI 1912028853
$65,321.21
in general payments reported to CMS, 2019-2025
29 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $83.40 · 2021: $307 · 2022: $22K · 2023: $31K · 2024: $12K · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $42K · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $41,833.33 |
| Food and Beverage | $1,194.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $62,726.66 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $462.89 | 2019-2022 | |
| Gilead Sciences, INC. | $426.99 | 2019-2024 | |
| Organogenesis INC. | $269.20 | 2021-2024 | Puraply |
| Astrazeneca Pharmaceuticals LP | $240.56 | 2022-2024 | Fasenra |
| Convatec INC. | $137.45 | 2023-2025 | |
| La Jolla Pharmaceutical Company | $128.60 | 2023 | Giapreza |
| Vertex Pharmaceuticals Incorporated | $119.50 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.85 | 2023 | Ofev |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $80.55 | 2019 | |
| Pfizer INC. | $60.82 | 2022 | |
| Bard Peripheral Vascular, INC. | $57.79 | 2022-2024 | Venclose Maven Catheter |
| Cashflow Solutions, LLC | $54.94 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Philips North America LLC | $54.04 | 2019-2020 | |
| Abbvie INC. | $52.99 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $48.98 | 2023 | Varithena Administration Pack |
| Terumo Medical Corporation | $35.85 | 2022 | |
| Solventum Corporation | $32.80 | 2024 | Kerramax Care, Promogran Prisma, 3m Coban |
| Amgen INC. | $32.30 | 2019 | |
| Kerecis Limited | $28.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $27.30 | 2021 | |
| Allergan, INC. | $21.28 | 2022 | |
| Baxter Healthcare | $20.07 | 2023 | Preveleak |
| Pacira Pharmaceuticals Incorporated | $19.09 | 2022 | |
| Cook Medical LLC | $17.14 | 2020 | |
| Amarin Pharma, INC. | $15.34 | 2019 | |
| Biocompatibles, INC. | $14.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.30 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obinna Nwobi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.